Historical Medicine

OBOMEDIA ENTERTAINMENT

The NHS guideline gap that refused her TPN and let her starve

OCT 13, 202620 MIN

Description

A young woman in an English hospital was denied TPN while doctors admitted the NHS had no policy - how did that guideline gap expose the system? The NHS guideline gap that refused her TPN and let her starve In this episode, we recount the case of Maeve Boothby O'Neill and the clinical decisions, policies, and historical research that shaped her care. The episode follows the medical timeline and the institutional gaps that left a treatable route of nutrition unprovided - what led to that absence? Person: Maeve Boothby O'Neill Age: 27 Date of death: autumn 2021 Cause of death recorded: malnutrition Treatment withheld: total parenteral nutrition (TPN) - Maeve developed severe ME/CFS that progressed until her body could not tolerate oral nutrition, a documented feature of the condition. - TPN, a standard intravenous nutrition used when oral intake is impossible, was available but not provided to her care team. - At the Exeter and Devon coroner's inquest, NHS director Dr. Anthony Hemsley testified there was no national policy or facilities for severe ME/CFS treatment in the UK. - The medical debate traces back decades: a 1970 paper by McEvedy and Beard declared outbreaks hysteria without examining patients, influencing later perceptions. - Subsequent cultural and academic voices, like Elaine Showalter’s 1997 book, further propagated non-clinical framings that shaped how ME/CFS was treated in practice. To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com. © 2026 OBOMEDIA. All rights reserved. This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: [email protected].